Superior Planning, LLC’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Superior Planning, LLC’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$889	Buy	+30	New	+$859	﹤0.01%	1774

Other funds holding LKFT

Gilead Sciences Foster City, California $1.46B AUM 71.23% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

Barometer Capital Management Toronto, Ontario, Canada $347M AUM 63.2% 1-Year Est. Return

denkapparat Operations Berlin, Germany $379M AUM 28.36% 1-Year Est. Return

Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return

Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Superior Planning, LLC's LKFT Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2026: 30 shares worth $889. The stake represents ﹤0.01% of the portfolio and ranks #1774 among its holdings.

49 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

Superior Planning, LLC held 30 shares of Lakefront Biotherapeutics American Depositary Shares worth $889 as of Q3 2026.
Lakefront Biotherapeutics American Depositary Shares was a new Superior Planning, LLC position in Q3 2026.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1774 holding.
49 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.